H

Heron Therapeutics
D

HRTX

1.72500
USD
0.01
(0.58%)
مغلق
حجم التداول
48,164
الربح لكل سهم
-2
العائد الربحي
-
P/E
-11
حجم السوق
262,363,723
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    B
    BMRN
    -0.525
    (-0.76%)
    68.215 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    E
    EXEL
    1.750
    (4.99%)
    36.830 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    المزيد
الأخبار
المقالات

العنوان: Heron Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.